Aldeyra Therapeutics aldeyra.com


Public lists: Pharma Startups (4733)

Aldeyra Therapeutics, formerly Neuron Systems, is a biotechnology company focused primarily on the development of products to treat immune-mediated, inflammatory, orphan, and other diseases that are thought to be related to a naturally occurring toxic chemical species known as free aldehydes. The company discovered and is developing NS2, a product candidate that is designed to trap and allow for disposal of free aldehydes, for the treatment of Sjogren-Larsson Syndrome (SLS), a rare disease cause...Show all

Aldeyra Therapeutics, formerly Neuron Systems, is a biotechnology company focused primarily on the development of products to treat immune-mediated, inflammatory, orphan, and other diseases that are thought to be related to a naturally occurring toxi...Show all

Company (IPO / Went public)

Phone: 617-513-9882

Fax:

15 New England Executive Park

Burlington, 01803
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Aldeyra Therapeutics $27.3M May 2, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Aldeyra Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Domain AssociatesVenture CapitalPrinceton, New Jersey, United StatesSeries B, Series A, Convertible Note
Johnson & Johnson InnovationCorporate VentureCambridge, Massachusetts, United StatesSeries B, Series A, Convertible Note
Access BridgeGap VenturesVenture CapitalCambridge, Massachusetts, United StatesSeries B
See all 3 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Compositions and methods of treating retinal disease Apr 14, 2017 Feb 20, 2018 Patent
Compositions and methods for the treatment of macular degeneration Dec 09, 2010 Nov 14, 2017 Patent
Toxic aldehyde related diseases and treatment Jan 23, 2014 Jun 27, 2017 Patent
Compositions and methods of treating retinal disease Feb 22, 2016 May 16, 2017 Patent
Peri-carbinols Dec 19, 2013 Mar 28, 2017 Patent
See all 11 patents